{
    "medicine_id": "a72ca7ffa7966fa2c5d7836e96a1814046f96c1f",
    "platform_id": "DB06720",
    "metadata": {
        "name": "Vpriv 400 U Injection powder for solution",
        "composition": "400 U Velaglucerase alfa",
        "clinical_particulars": {
            "therapeutic_indications": "Velaglucerase alfa is a hydrolytic lysosomal glucocerebroside specific enzyme indicated for long term enzyme replacement therapy for pediatric and adult patients with type 1 Gaucher disease",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}